Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU

Gastroenterologia y Hepatologia

Volumn 36, Issue 2, 2013, Pages 104-114

  Gomollón, Fernando ^a   García López, Santiago ^b   Sicilia, Beatriz ^c   Gisbert, Javier P ^d   Hinojosa, Joaquín ^e  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^d Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^e HOSPITAL DE MANISES   (Spain)

Author keywords

Clinical Practice Guidelines; GRADE methodology; Therapy; Ulcerative colitis

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; HEPARIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; PREDNISONE; SALICYLIC ACID DERIVATIVE; STEROID; TACROLIMUS;

ARTICLE; COLON RESECTION; CROHN DISEASE; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; PARENTERAL NUTRITION; PRACTICE GUIDELINE; QUESTIONNAIRE; ULCERATIVE COLITIS;

ALGORITHMS; COLITIS, ULCERATIVE; HUMANS;

EID: 84873995540     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2012.09.006     Document Type: Article

References (25)

1. Lennard-Jonnes J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 24(Suppl. 170):2-6.
2. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
3. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
4. Arín Letamendía A., Borda Celaya F., Burusco Paternain M.J., Prieto Martínez C., Martínez Echeverría A., Elizalde Apestegui I., et al. Alta incidencia de la enfermedad inflamatoria intestinal en Navarra (España). Resultados de un estudio prospectivo y poblacional. Gastroenterol Hepatol 2008, 31:111-116.
5. Gassull M.A., Gomollón F., Hinojosa J., Obrador A. Enfermedad inflamatoria intestinal 2007, Arán, Madrid. 3rd ed.
6. Targan S.R., Shanahan F., Karp L.C. Inflammatory bowel disease 2010, Wiley-Blackwell, Oxford.
7. Travis S.P.L., Stange E.F., Lémann M., Oresland T., Bemelman W.A., Chowers Y., et al. European evidence-based consensus on the management of ulcerative colitis: current management. Journal of Crohn's and Colitis 2008, 2:24-62.
8. Carter M.J., Lobo A.J., Travis S.P.L. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl. 5):V1-V16. on behalf of the IBD Section of the British Society of Gastroenterology.
9. Kornbluth A., Sachar DB, on behalf of the Practice Parameters Committee of the American College of Gastroenterology Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 2010, 105:501-523.
10. Bernstein C.N., Fried M., Krabshuis J.H., Cohen H., Eliakim R., Fedall S., et al. World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010, 16:112-124.
11. Ooi C.J., Fock K.M., Makharia G.K., Goh K.L., Ling K.L., Hilmi I., et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol 2010, 25:453-468.
12. Hani A.C., Galiano M.T., Márquez J.R., Juliao F., Castaño R., Pineda L.F., et al. Consenso colombiano de enfermedad inflamatoria intestinal. Revista Colombiana de Gastroenterología 2011, S1-S42.
13. Domènech E., Esteve M., Gomollón F., Hinojosa J., Panés J., Obrador A., Gassull M.A. GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease. Gastroenterol Hepatol 2005, 28:126-134.
14. López-SanRomán A., Obrador A., Fortún J., Muñoz P., Gassull M.A. Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update. Gastroenterol Hepatol 2006, 29:81-84.
15. Cabriada J.L., Domènech E., Gomollón F., González-Carro P., González-Lara V., Hinojosa J., et al. Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease. Gastroenterol Hepatol 2006, 29:85-92.
16. The GRADE Working Group Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. BMC Health Serv Res 2004, 4:38.
17. The AGREE Collaboration Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Safe Health Care 2003, 12:18-23.
18. Travis S.P.L., Higgins P.D.R., Orchard T., Van Der Woude C.J., Panaccione R., Panés J., et al. Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther 2011, 34:113-124.
19. Stange E.F., Travis S.P.L., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
20. Marzo Castillejo M., Montaño Barrientos A. Sistema GRADE para la toma de decisiones clínicas y elaboración de recomendaciones y guías de práctica clínica. Aten Primaria 2007, 39:457-460.
21. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
22. Falck-Ytter Y., Kunz R., Guyatt G.H., Schünemann H. How strong is evidence?. Am J Gastroenterol 2008, 103:1334-1338.
23. Odes S., Vardi H., Friger M., Wolters F., Russel M.G., Riis L., et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006, 131:719-728.
24. Gisbert J.P., Gomollón F., Hinojosa J., López San Román A. Adherence of gastroenterologists to European Crohn's and Colitis Organization consensus on ulcerative colitis: a real-life survey in Spain. J Crohns Colitis 2010, 4:567-574.
25. Alonso-Coello P., Irfan A., Solà I., Gich I., Delgado-Noguera M., Rigau D., et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 2010, 19:e58.